Rapamycin and ageing: when, for how long, and how much?

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of genetics and genomics = Yi chuan xue bao

• Publication date

  2014-09-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jgg.2014.06.009PMID 25269671PMCID PMC4401992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The caloric restriction paradigm

  2015cited by this paper
• Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction

  2014influential reference
• Rapamycin extends life and health in C57BL/6 mice.

  2014influential reference
• Preserving Youth: Does Rapamycin Deliver?

  2013cited by this paper
• Late‐life rapamycin treatment reverses age‐related heart dysfunction

  2013cited by this paper
• mTOR is a key modulator of ageing and age-related disease

  2013influential reference
• mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome

  2013influential reference
• Longevity and aging

  2013cited by this paper
• mTOR Inhibition: From Aging to Autism and Beyond

  2013cited by this paper
• Rapamycin extends murine lifespan but has limited effects on aging.

  2013cited by this paper
• The caloric restriction paradigm: Implications for healthy human aging

  2012cited by this paper
• mTOR signaling in growth control and disease.

  2012cited by this paper
• TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO.

  2012cited by this paper
• Rapamycin slows aging in mice

  2012influential reference
• Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity

  2012cited by this paper
• Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice

  2011cited by this paper
• Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice.

  2011cited by this paper
• With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging.

  2010cited by this paper
• Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila melanogaster

  2010cited by this paper
• drr‐2 encodes an eIF4H that acts downstream of TOR in diet‐restriction‐induced longevity of C. elegans

  2010cited by this paper
• Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span

  2009cited by this paper
• 4E-BP extends lifespan upon dietary restriction by enhancing mitochondrial activity in Drosophila.

  2009cited by this paper
• Rapamycin fed late in life extends lifespan in genetically heterogeneous mice

  2009influential reference
• mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells

  2009cited by this paper
• Yeast life span extension by depletion of 60s ribosomal subunits is mediated by Gcn4.

  2008cited by this paper
• Design of aging intervention studies: the NIA interventions testing program

  2008cited by this paper
• Ruminations on dietary restriction and aging

  2007cited by this paper
• Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans

  2007cited by this paper
• MSN2 and MSN4 Link Calorie Restriction and TOR to Sirtuin-Mediated Lifespan Extension in Saccharomyces cerevisiae

  2007cited by this paper
• Extension of chronological life span in yeast by decreased TOR pathway signaling.

  2006cited by this paper
• Overview of caloric restriction and ageing.

  2005cited by this paper
• Regulation of Yeast Replicative Life Span by TOR and Sch9 in Response to Nutrients

  2005influential reference
• TOR pathway: linking nutrient sensing to life span.

  2004cited by this paper
• Chronological aging‐independent replicative life span regulation by Msn2/Msn4 and Sod2 in Saccharomyces cerevisiae

  2004cited by this paper
• Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway.

  2004influential reference
• The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span

  2004cited by this paper
• Genetics: Influence of TOR kinase on lifespan in C. elegans

  2003cited by this paper
• Metabolism and life span determination in C. elegans

  2003cited by this paper
• Regulation of Longevity and Stress Resistance by Sch9 in Yeast

  2001cited by this paper

• mTOR mediates airway epithelial E-cadherin disruption in toluene diisocyanate-induced asthma.

  2025cites this paper
• The bioavailability and blood levels of low-dose rapamycin for longevity in real-world cohorts of normative aging individuals

  2025cites this paper
• Biomarkers of aging: from molecules and surrogates to physiology and function.

  2025cites this paper
• Effect of preoperative rapamycin supplementation on perioperative clinical frailty and cognitive performance in a murine model undergoing anesthesia and surgery

  2025influential citation
• Rapamycin Reduces Carcinogenesis and Enhances Survival in Mice when Administered after Nonlethal Total-Body Irradiation

  2024cites this paper
• Turning Back the Clock: A Retrospective Single-Blind Study on Brain Age Change in Response to Nutraceuticals Supplementation vs. Lifestyle Modifications

  2023cites this paper
• Towards disease-oriented dosing of rapamycin for longevity: does aging exist or only age-related diseases?

  2023cites this paper
• A masked, placebo-controlled, randomized clinical trial evaluating safety and the effect on cardiac function of low-dose rapamycin in 17 healthy client-owned dogs

  2023cites this paper
• mTOR Inhibition via Low-Dose, Pulsed Rapamycin with Intraovarian Condensed Platelet Cytokines: An Individualized Protocol to Recover Diminished Reserve?

  2023cites this paper
• mTOR Complex 1 Content and Regulation Is Adapted to Animal Longevity

  2022cites this paper
• Innate Immunity Dysregulation In Aging Eye and Therapeutic Interventions.

  2022cites this paper
• Rapamycin treatment early in life reprograms aging: hyperfunction theory and clinical practice

  2022cites this paper
• Sirolimus treatment induces dose-dependent involution of the thymus with elevated cellular respiration in BALB/c mice.

  2022cites this paper
• Lessons Learned From Blue Zones, Lifestyle Medicine Pillars and Beyond: An Update on the Contributions of Behavior and Genetics to Wellbeing and Longevity

  2022cites this paper
• Metformin Treatment in Old Rats and Effects on Mitochondrial Integrity

  2021cites this paper
• Cellular Senescence: Mechanisms and Therapeutic Potential

  2021cites this paper
• A ride through the epigenetic landscape: aging reversal by reprogramming

  2021cites this paper
• No limit to maximal lifespan in humans: how to beat a 122-year-old record

  2021cites this paper
• Intragenic repeat expansion in the cell wall protein gene HPF1 controls yeast chronological aging

  2020cites this paper
• The mystery of the ketogenic diet: benevolent pseudo-diabetes

  2019cites this paper
• Senescence in aging and disorders of the central nervous system

  2019cites this paper
• Intragenic repeat expansions control yeast chronological aging

  2019cites this paper
• Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools

  2019cites this paper
• Fasting and rapamycin: diabetes versus benevolent glucose intolerance

  2019cites this paper
• Body weight at 10 years of age and change in body composition between 8 and 10 years of age were related to survival in a longitudinal study of 39 Labrador retriever dogs

  2019cites this paper
• Rapamycin for longevity: opinion article

  2019cites this paper
• Disease or not, aging is easily treatable

  2018cites this paper
• mTOR inhibitors for treatment of low-risk prostate cancer.

  2018cites this paper
• Reduced expression of C/EBPβ-LIP extends health and lifespan in mice

  2018cites this paper
• Antiaging and Performance-Enhancing Drugs

  2018cites this paper
• Interventions for age-related diseases

  2018cites this paper
• A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs

  2017cites this paper
• Anti-aging Drugs: From Basic Research to Clinical Practice

  2017cites this paper
• The role of the TOR pathway in mediating the link between nutrition and longevity.

  2017cites this paper
• Building for the future: essential infrastructure for rodent ageing studies

  2016cites this paper
• Gerosuppression by pan-mTOR inhibitors

  2016cites this paper
• The dog aging project: translational geroscience in companion animals

  2016cites this paper
• The Biology of Aging

  2016cites this paper
• Comparative idiosyncrasies in life extension by reduced mTOR signalling and its distinctiveness from dietary restriction

  2016influential citation
• Anti-aging pharmacology: Promises and pitfalls.

  2016influential citation
• The Vital Role of Pathology in Improving Reproducibility and Translational Relevance of Aging Studies in Rodents

  2016cites this paper
• Article in Press G Model Mechanisms of Ageing and Development Interventions for Age-related Diseases: Shifting the Paradigm Article in Press G Model

  year unknowncites this paper